Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 1, 2006, Pages 45-52

  Zeiger, Robert S ^a,b   Szefler, Stanley J ^c   Phillips, Brenda R ^d   Schatz, Michael ^b   Martinez, Fernando D ^e   Chinchilli, Vernon M ^d   Lemanske Jr , Robert F ^f   Strunk, Robert C ^g   Larsen, Gary ^c   Spahn, Joseph D ^c   Bacharier, Leonard B ^g   Bloomberg, Gordon R ^g   Guilbert, Theresa W ^e   Heldt, Gregory ^a   Morgan, Wayne J ^e   Moss, Mark H ^f   Sorkness, Christine A ^f   Taussig, Lynn M ^c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Kaiser Permanente San Diego ^*  (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f University of Wisconsin Health   (United States)

^g WASHINGTON UNIVERSITY   (United States)

Author keywords

Asthma control days; Asthma control outcomes; Asthma Control Questionnaire; Exhaled nitric oxide; Fluticasone propionate; Inhaled corticosteroids; Leukotriene receptor antagonists; Montelukast; Pulmonary response

Indexed keywords

FLUTICASONE PROPIONATE; MONTELUKAST; NITRIC OXIDE;

ADOLESCENT; ARTICLE; BRONCHODILATING ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE MARKER; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD PERSISTENT ASTHMA; MODERATE PERSISTENT ASTHMA; MULTICENTER STUDY; PATIENT ASSESSMENT; PEAK EXPIRATORY FLOW; PNEUMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STRUCTURED QUESTIONNAIRE; TREATMENT OUTCOME; VALIDATION STUDY;

ACETATES; ADOLESCENT; ANDROSTADIENES; ASTHMA; CHILD; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; NITRIC OXIDE; QUINOLINES;

EID: 29544438173     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.10.012     Document Type: Article

References (41)

1. National Asthma Education and Prevention Program Expert panel report: guidelines for the diagnosis and management of asthma update on selected topics - 2002 J Allergy Clin Immunol 110 suppl 2002 S141 S219
2. The Global Initiative for Asthma 2002 US Department of Health and Human Services Public Health Service, NIH, NHLBI Bethesda (MD) NIH Publication no. 02-3659
3. K.F. Rabe, M. Adachi, C.K. Lai, J.B. Soriano, P.A. Vermeire, and K.B. Weiss Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys J Allergy Clin Immunol 114 2004 40 47
4. Childhood Asthma Management Program (CAMP) Research Group long-term effects of budesonide or nedocromil in children with asthma N Engl J Med 343 2000 1054 1063
5. B. Knorr, J. Matz, J.A. Bernstein, H. Nguyen, B.C. Seidenberg, and T.F. Reiss Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group JAMA 279 1998 1181 1186
6. K. Malmstrom, G. Rodriguez-Gomez, J. Guerra, C. Villaran, A. Pineiro, and L.X. Wei Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group Ann Intern Med 130 1999 487 495
7. F.M. Ducharme Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence BMJ 326 2003 621 625
8. F.M. Ducharme Inhaled corticosteroids versus leukotriene antagonists as first-line therapy for asthma: a systematic review of current evidence Treat Respir Med 3 2004 399 405
9. J.F. Maspero, E. Duenas-Meza, B. Volovitz, D.C. Pinacho, L. Kosa, and F. Vrijens Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy Curr Med Res Opin 17 2001 96 104
10. I. Stelmach, J. Jerzynska, and P. Kuna A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma Clin Exp Allergy 32 2002 264 269
11. S.J. Szefler, B.R. Phillips, F.D. Martinez, V.M. Chinchilli, R.F. Lemanske, and R.C. Strunk Characterization of within-subject responses to fluticasone and montelukast in childhood asthma J Allergy Clin Immunol 115 2005 233 242
12. J. Zhang, C. Yu, S.T. Holgate, and T.F. Reiss Variability and lack of predictive ability of asthma end-points in clinical trials Eur Respir J 20 2002 1102 1109
13. R.C. Strunk, S.J. Szefler, B.R. Phillips, R.S. Zeiger, V.M. Chinchilli, and G. Larsen Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children J Allergy Clin Immunol 112 2003 883 892
14. A.S. Vathenen, A.J. Knox, A. Wisniewski, and A.E. Tattersfield Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma Am Rev Respir Dis 143 1991 1317 1321
15. N.H. Gershman, H.H. Wong, J.T. Liu, and J.V. Fahy Low- and high-dose fluticasone propionate in asthma; effects during and after treatment Eur Respir J 15 2000 11 18
16. M. Laviolette, K. Malmstrom, S. Lu, P. Chervinsky, J.C. Pujet, and I. Peszek Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group Am J Respir Crit Care Med 160 1999 1862 1868
17. E.F. Juniper, P.M. O'Byrne, G.H. Guyatt, P.J. Ferrie, and D.R. King Development and validation of a questionnaire to measure asthma control Eur Respir J 14 1999 902 907
18. N. Kissoon, L. Duckworth, K. Blake, S. Murphy, and P.E. Silkoff Exhaled nitric oxide measurements in childhood asthma: techniques and interpretation Pediatr Pulmonol 28 1999 282 296
19. American Thoracic Society Standardization of spirometry, 1994 update Am J Respir Crit Care Med 152 1995 1107 1136
20. M.D. Goldman, R. Carter, R. Klein, G. Fritz, B. Carter, and P. Pachucki Within- and between-day variability of respiratory impedance, using impulse oscillometry in adolescent asthmatics Pediatr Pulmonol 34 2002 312 319
21. A. Marotta, M.D. Klinnert, M.R. Price, G.L. Larsen, and A.H. Liu Impulse oscillometry provides an effective measure of lung dysfunction in 4-year-old children at risk for persistent asthma J Allergy Clin Immunol 112 2003 317 322
22. L.I. Lin A concordance correlation coefficient to evaluate reproducibility Biometrics 45 1989 255 268
23. D.A. Stempel, and A.L. Fuhlbrigge Defining the responder in asthma therapy J Allergy Clin Immunol 115 2005 466 469
24. M.L. Garcia, U. Wahn, L. Gilles, A. Swern, C.A. Tozzi, and P. Polos Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study Pediatrics 116 2005 360 369
25. N.K. Ostrom, B.A. Decotiis, W.R. Lincourt, L.D. Edwards, K.M. Hanson, and R. Carranza Jr. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma J Pediatr 147 2005 213 220
26. R.S. Zeiger, S.R. Bird, M.S. Kaplan, M. Schatz, D.S. Pearlman, and E.J. Orav Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial Am J Med 118 2005 649 657
27. S.J. Szefler, R.J. Martin, T.S. King, H.A. Boushey, R.M. Cherniack, and V.M. Chinchilli Significant variability in response to inhaled corticosteroids for persistent asthma J Allergy Clin Immunol 109 2002 410 418
28. S. Shingo, J. Zhang, and T.F. Reiss Correlation of airway obstruction and patient-reported endpoints in clinical studies Eur Respir J 17 2001 220 224
29. K.A. Meyer, J.M. Arduino, N.C. Santanello, B.A. Knorr, and H. Bisgaard Response to montelukast among subgroups of children aged 2 to 14 years with asthma J Allergy Clin Immunol 111 2003 757 762
30. T.F. Reiss, P. Chervinsky, R.J. Dockhorn, S. Shingo, B. Seidenberg, and T.B. Edwards Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group Arch Intern Med 158 1998 1213 1220
31. L.P. Malmberg Exhaled nitric oxide in childhood asthma - time to use inflammometry rather than spirometry? J Asthma 41 2004 511 520
32. B.S. Bochner, and W.W. Busse Allergy and asthma J Allergy Clin Immunol 115 2005 953 959
33. A.M. Wilson, L.C. Orr, E.J. Sims, O.J. Dempsey, and B.J. Lipworth Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma Am J Respir Crit Care Med 162 2000 1297 1301
34. O.J. Dempsey, G. Kennedy, and B.J. Lipworth Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma J Allergy Clin Immunol 109 2002 68 74
35. H.A. Boushey, C.A. Sorkness, T.S. King, S.D. Sullivan, J.V. Fahy, and S.C. Lazarus Daily versus as-needed corticosteroids for mild persistent asthma N Engl J Med 352 2005 1519 1528
36. S. Carra, L. Gagliardi, S. Zanconato, M. Scollo, N. Azzolin, and F. Zacchello Budesonide but not nedocromil sodium reduces exhaled nitric oxide levels in asthmatic children Respir Med 95 2001 734 739
37. C. Mondino, G. Ciabattoni, P. Koch, R. Pistelli, A. Trove, and P.J. Barnes Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children J Allergy Clin Immunol 114 2004 761 767
38. H. Bisgaard, L. Loland, and J.A. Oj NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast Am J Respir Crit Care Med 160 1999 1227 1231
39. F. Buchvald, E. Baraldi, S. Carraro, B. Gaston, J.J. De, and M.W. Pijnenburg Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years J Allergy Clin Immunol 115 2005 1130 1136
40. S.L. Jones, J. Kittelson, J.O. Cowan, E.M. Flannery, R.J. Hancox, and C.R. McLachlan The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control Am J Respir Crit Care Med 164 2001 738 743
41. A.D. Smith, J.O. Cowan, K.P. Brassett, S. Filsell, C. McLachlan, and G. Monti-Sheehan Exhaled nitric oxide: a predictor of steroid response Am J Respir Crit Care Med 172 2005 453 459